IL115744A - Peptides comprising a subsequence of human cartilage glycoprotein - 39 - Google Patents
Peptides comprising a subsequence of human cartilage glycoprotein - 39Info
- Publication number
- IL115744A IL115744A IL11574495A IL11574495A IL115744A IL 115744 A IL115744 A IL 115744A IL 11574495 A IL11574495 A IL 11574495A IL 11574495 A IL11574495 A IL 11574495A IL 115744 A IL115744 A IL 115744A
- Authority
- IL
- Israel
- Prior art keywords
- peptides
- autoantigen
- seq
- pct
- sec
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 7
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 7
- 101000883515 Homo sapiens Chitinase-3-like protein 1 Proteins 0.000 title 1
- 102000054350 human CHI3L1 Human genes 0.000 title 1
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 2
- 210000001188 articular cartilage Anatomy 0.000 abstract 2
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 102000043131 MHC class II family Human genes 0.000 abstract 1
- 108091054438 MHC class II family Proteins 0.000 abstract 1
- 241000699670 Mus sp. Species 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 206010003246 arthritis Diseases 0.000 abstract 1
- 238000003149 assay kit Methods 0.000 abstract 1
- 230000006378 damage Effects 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 210000000987 immune system Anatomy 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Rehabilitation Therapy (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Transplantation (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP94203128 | 1994-10-27 | ||
| EP95200886 | 1995-04-07 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL115744A0 IL115744A0 (en) | 1996-01-19 |
| IL115744A true IL115744A (en) | 2000-07-16 |
Family
ID=26136688
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL11574495A IL115744A (en) | 1994-10-27 | 1995-10-24 | Peptides comprising a subsequence of human cartilage glycoprotein - 39 |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US5736507A (da) |
| EP (1) | EP0733065B1 (da) |
| JP (1) | JP3755894B2 (da) |
| KR (1) | KR100485979B1 (da) |
| CN (1) | CN1161379C (da) |
| AT (1) | ATE177756T1 (da) |
| AU (1) | AU696827B2 (da) |
| BR (1) | BR9506377A (da) |
| CA (1) | CA2173874A1 (da) |
| DE (1) | DE69508380T2 (da) |
| DK (1) | DK0733065T3 (da) |
| ES (1) | ES2130672T3 (da) |
| FI (1) | FI118472B (da) |
| GR (1) | GR3030296T3 (da) |
| HU (1) | HU218027B (da) |
| IL (1) | IL115744A (da) |
| MX (1) | MX9602495A (da) |
| NO (1) | NO316703B1 (da) |
| NZ (1) | NZ295659A (da) |
| PL (1) | PL183761B1 (da) |
| RU (1) | RU2178797C2 (da) |
| TR (1) | TR199501326A2 (da) |
| WO (1) | WO1996013517A1 (da) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5843449A (en) * | 1996-03-25 | 1998-12-01 | Akzo Nobel N.V. | Proteins and novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases |
| US6881824B1 (en) | 1996-04-24 | 2005-04-19 | Akzo Nobel N.V. | Peptides suitable for use in antigen specific immunosuppressive therapy |
| IL120561A0 (en) * | 1996-04-24 | 1997-07-13 | Akzo Nobel Nv | Peptides suitable for use in immunosuppressive therapy |
| NZ334714A (en) * | 1996-09-18 | 2000-08-25 | Zetesis Spa | Liver proteins as agents against autoimmune diseases |
| EP0947524A1 (en) * | 1998-03-30 | 1999-10-06 | Upither B.V. | Novel peptides for the treatment of autoimmune diseases |
| BR9912378A (pt) * | 1998-07-23 | 2001-04-17 | Akzo Nobel Nv | Peptìdeo, composição farmacêutica, uso de um ou mais dos peptìdeos, e, composição para diagnóstico. |
| WO2000004917A2 (en) * | 1998-07-23 | 2000-02-03 | Akzo Nobel N.V. | USE OF HC gp-39 IN IMMUNE DISEASES |
| EP1137411B1 (en) * | 1998-12-09 | 2006-12-06 | YEDA RESEARCH AND DEVELOPMENT Co. LTD. | Palladium-substituted bacteriochlorophyll derivatives and use thereof |
| CA2386398A1 (en) * | 1999-10-18 | 2001-04-26 | Akzo Nobel Nv | Modified peptides and peptidomimetics for use in immunotherapy |
| US7265208B2 (en) * | 2001-05-01 | 2007-09-04 | The Regents Of The University Of California | Fusion molecules and treatment of IgE-mediated allergic diseases |
| JP2006508014A (ja) * | 2001-07-24 | 2006-03-09 | イエール・ユニバーシテイ | キチナーゼおよびキチナーゼ様分子、ならびに炎症性疾患に関する方法、組成物およびキット |
| EP1729805A4 (en) * | 2004-02-25 | 2008-11-26 | Medimmune Inc | METHODS AND COMPOSITIONS RELATED TO CHITINASES AND CHITINASE-MOLECULARS AND MODULATION OF OSTEOCLASTS |
| WO2007027748A2 (en) * | 2005-08-31 | 2007-03-08 | Medimmune, Inc. | C/clp antagonists and methods of use thereof |
| RU2302872C9 (ru) * | 2006-06-22 | 2008-12-20 | Общество С Ограниченной Ответственностью "Сиа Пептайдс" | Средство, нормализующее функции хрящевой ткани, и способ его получения |
| GB0710529D0 (en) | 2007-06-01 | 2007-07-11 | Circassia Ltd | Vaccine |
| NZ583362A (en) | 2007-08-15 | 2012-06-29 | Circassia Ltd | Peptide with reduced dimer formation |
| EP2331124A1 (en) * | 2008-08-15 | 2011-06-15 | Circassia Limited | T-cell antigen peptide from allergen for stimulation of il-10 production |
| ES2378870T5 (es) | 2008-08-15 | 2016-02-03 | Circassia Limited | Vacuna que comprende péptidos Amb a 1 para uso en el tratamiento de alergia a ambrosía |
| HRP20150317T1 (hr) | 2009-02-05 | 2015-04-24 | Circassia Limited | Peptidi trave za cjepivo |
| AU2010311515B2 (en) * | 2009-10-27 | 2014-02-20 | Erytech Pharma | Composition to induce specific immune tolerance |
| EP3344575B1 (en) | 2015-09-04 | 2020-04-15 | SQZ Biotechnologies Company | Intracellular delivery of biomolecules to cells comprising a cell wall |
| CA3023092A1 (en) | 2016-05-03 | 2017-11-09 | Sqz Biotechnologies Company | Intracellular delivery of biomolecules to induce tolerance |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6323898A (ja) * | 1986-07-16 | 1988-02-01 | Dainippon Pharmaceut Co Ltd | 新規ポリペプチド及びそれをコ−ドするｄｎａ並びにそれらの製法 |
| IL92629A0 (en) * | 1989-12-10 | 1990-08-31 | Yeda Res & Dev | Direct binding of t-cell epitopes to mhc gene products on intact living antigen presenting cells and the use thereof for identifying epitopes causing autoimmune diseases and pharmaceutical compositions for treating such diseases |
| GB9125024D0 (en) * | 1991-11-25 | 1992-01-22 | Kirby Julian | Rheumatoid arthritus treatment |
| JPH07506810A (ja) * | 1992-02-10 | 1995-07-27 | デューク・ユニバーシティ | 自己抗原である病原性のｔ細胞エピトープおよびｂ細胞エピトープに対する寛容性を誘導するための合成ペプチドの使用 |
| AU4920093A (en) * | 1992-09-14 | 1994-04-12 | Brigham And Women's Hospital | Reagents and methods for treating rheumatoid arthritis |
| CA2164498C (en) * | 1993-07-09 | 2007-09-11 | Paul A. Price | Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices |
-
1995
- 1995-10-24 IL IL11574495A patent/IL115744A/xx not_active IP Right Cessation
- 1995-10-25 EP EP95937008A patent/EP0733065B1/en not_active Expired - Lifetime
- 1995-10-25 AT AT95937008T patent/ATE177756T1/de not_active IP Right Cessation
- 1995-10-25 KR KR1019960702711A patent/KR100485979B1/ko not_active Expired - Fee Related
- 1995-10-25 HU HU9601401A patent/HU218027B/hu not_active IP Right Cessation
- 1995-10-25 PL PL95315198A patent/PL183761B1/pl not_active IP Right Cessation
- 1995-10-25 CA CA002173874A patent/CA2173874A1/en not_active Abandoned
- 1995-10-25 NZ NZ295659A patent/NZ295659A/en unknown
- 1995-10-25 JP JP51430696A patent/JP3755894B2/ja not_active Expired - Fee Related
- 1995-10-25 ES ES95937008T patent/ES2130672T3/es not_active Expired - Lifetime
- 1995-10-25 US US08/619,645 patent/US5736507A/en not_active Expired - Fee Related
- 1995-10-25 BR BR9506377A patent/BR9506377A/pt not_active Application Discontinuation
- 1995-10-25 MX MX9602495A patent/MX9602495A/es not_active IP Right Cessation
- 1995-10-25 DE DE69508380T patent/DE69508380T2/de not_active Expired - Fee Related
- 1995-10-25 WO PCT/EP1995/004201 patent/WO1996013517A1/en not_active Ceased
- 1995-10-25 DK DK95937008T patent/DK0733065T3/da active
- 1995-10-25 AU AU39252/95A patent/AU696827B2/en not_active Ceased
- 1995-10-25 CN CNB951909444A patent/CN1161379C/zh not_active Expired - Fee Related
- 1995-10-25 RU RU96115937/04A patent/RU2178797C2/ru not_active IP Right Cessation
- 1995-10-27 TR TR95/01326A patent/TR199501326A2/xx unknown
-
1996
- 1996-06-25 FI FI962619A patent/FI118472B/fi active IP Right Grant
- 1996-06-26 NO NO19962695A patent/NO316703B1/no unknown
-
1999
- 1999-05-21 GR GR990401382T patent/GR3030296T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL115744A (en) | Peptides comprising a subsequence of human cartilage glycoprotein - 39 | |
| Ugrinovic et al. | A single nonamer from the Yersinia 60-kDa heat shock protein is the target of HLA-B27-restricted CTL response in Yersinia-induced reactive arthritis | |
| NZ332311A (en) | Use of autoantigen HC gp-39 and proteins structurally related thereto in immunotherapy of autoimmune diseases particularly rheumatoid arthritis | |
| ATE167062T1 (de) | Verfahren zur anregung antigenspezifischer t- zelltoleranz | |
| PL336714A1 (en) | Antigen loci prrsv identifying the peptidic sequences of prrs virus for use in vaccines or diagnostic tests | |
| NZ332427A (en) | Peptides suitable for use in antigen specific immunosuppressive therapy | |
| DE69638024D1 (de) | Melanoma antigene p15 und deren anwendung in diagnostischen und therapeutischen verfahren | |
| DK0841939T3 (da) | Terapeutiske midler og autoimmune sygdomme | |
| IL92629A0 (en) | Direct binding of t-cell epitopes to mhc gene products on intact living antigen presenting cells and the use thereof for identifying epitopes causing autoimmune diseases and pharmaceutical compositions for treating such diseases | |
| ATE248602T1 (de) | Verfahren zur isolierung von cda-präsentierten antigenen, cd1-präsentierte antigeneenthaltende impfstoffe und in besagten verfahren verwendbare zelllinien | |
| DE69638145D1 (de) | Verfahren zur herbeiführung einer immuntoleranz mit hilfe von immuntoxinen | |
| GR3031990T3 (en) | Novel peptides for use in treatment of t-cell mediated cartilage destruction in autoimmune diseases | |
| Levy et al. | Role of self and foreign antigenic determinants in allogeneic and self-restricted cytotoxic T cell recognition. | |
| TR200100175T2 (tr) | Otoimmün hastalıkların immünoterapisinde kullanılmak üzere yeni peptitler. | |
| Elves | Immunology of cartilage | |
| Goldman et al. | The impact of maternal infection or immunization on early-onset autoimmune diabetes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |